Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium

被引:10
|
作者
Piccini, Jonathan P. [1 ,2 ]
Clark, Richard L. [3 ]
Kowey, Peter R. [4 ,5 ]
Mittal, Suneet [6 ]
Dunnmon, Preston [7 ]
Stockbridge, Norman [7 ]
Reiffel, James A. [8 ]
Turakhia, Mintu P. [9 ,10 ]
Ziegler, Paul D. [3 ]
Kleiman, Robert B. [11 ]
Ismat, Fraz [12 ]
Sager, Philip [13 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC 27708 USA
[2] Duke Clin Res Inst, Durham, NC 27705 USA
[3] Mechron Diagnost & Monitoring Res, Mounds View, MN USA
[4] Lankenau Heart Inst, Philadelphia, PA USA
[5] Jefferson Med Coll, Philadelphia, PA USA
[6] Valley Hlth Syst, Ridgewood, NJ USA
[7] US FDA, Div Cardiovasc & Renal Prod, Rockville, MD 20857 USA
[8] Columbia Univ, Div Cardiol, Med Ctr, New York, NY USA
[9] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA
[10] Stanford Univ, Palo Alto, CA 94304 USA
[11] eRes Technol Inc ERT, Philadelphia, PA USA
[12] Bristol Myers Squibb, Princeton, NJ USA
[13] Stanford Univ, Stanford, CA 94305 USA
关键词
ATRIAL-FIBRILLATION; PROARRHYTHMIC RISK; HEPATITIS-C; SOFOSBUVIR; ARRHYTHMIAS; AMIODARONE; DEVICES; FOCUS;
D O I
10.1016/j.ahj.2017.01.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This white paper, prepared by members of the Cardiac Safety Research Consortium (CSRC), discusses important issues regarding scientific and clinical aspects of long-term electrocardiographic safety monitoring during clinical drug development. To promote multistakeholder discussion of this topic, a Cardiac Safety Research Consortium sponsored Think Tank was held on 2 December 2015 at the American College of Cardiology's Heart House in Washington, DC. The goal of the Think Tank was to explore how and under what circumstances new and evolving ambulatory monitoring technologies could be used to improve and streamline drug development. This paper provides a detailed summary of discussions at the Think Tank: it does not represent regulatory guidance.
引用
收藏
页码:156 / 169
页数:14
相关论文
共 50 条
  • [21] Electrocardiographic patterns and long-term clinical outcome in cardiac resynchronization therapy
    Kronborg, Mads B.
    Nielsen, Jens C.
    Mortensen, Peter T.
    EUROPACE, 2010, 12 (02): : 216 - 222
  • [22] PRELIMINARY-REPORT - LONG-TERM SAFETY OF ZOMEPIRAC
    HONIG, S
    JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 20 (5-6): : 392 - 396
  • [23] Cardiac Safety and Clinical Efficacy of High Dose Domperidone for Long-Term Treatment of Gastroparesis
    Woods, Kevin
    Sarosiek, Irene
    Espino, Karina
    Ramirez, Marisol
    Siddiqui, Tariq
    McCallum, Richard
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S685 - S685
  • [24] Long-term Research Project started SAFETY OF NANOMATERIALS
    不详
    ZENTRALBLATT FUR ARBEITSMEDIZIN ARBEITSSCHUTZ UND ERGONOMIE, 2012, 62 (03): : 147 - 147
  • [25] Long-term effectiveness and safety of liraglutide in clinical practice
    Ponzani, P.
    MINERVA ENDOCRINOLOGICA, 2013, 38 (01) : 103 - 112
  • [26] Long-term Effectiveness and Safety of Liraglutide in Clinical Practice
    Ponzani, Paola
    Rossi, Maria Chiara
    Nicolucci, Antonio
    DIABETES, 2014, 63 : A259 - A259
  • [27] Assessing Long-Term Drug Safety: Lessons (Re) Learned from Raptiva
    Seminara, Nicole M.
    Gelfand, Joel M.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2010, 29 (01) : 16 - 19
  • [28] Troponin measurements during drug development-considerations for monitoring and management of potential cardiotoxicity: An educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration
    Newby, L. Kristin
    Rodriguez, Ignacio
    Finkle, John
    Becker, Richard C.
    Hicks, Karen A.
    Hausner, Elizabeth
    Chesler, Ruth
    Harper, Courtney
    Targum, Shari
    Berridge, Brian R.
    Lewis, Eric
    Walker, Dana B.
    Dollery, Colin
    Turner, J. Rick
    Krucoff, Mitchell W.
    AMERICAN HEART JOURNAL, 2011, 162 (01) : 64 - 73
  • [29] Safety study of long-term video-electroencephalogram monitoring
    Ley, M.
    Vivanco, R.
    Massot, A.
    Jimenez, J.
    Roquer, J.
    Rocamora, R.
    NEUROLOGIA, 2014, 29 (01): : 21 - 26
  • [30] Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research Consortium
    Heller, Simon
    Darpoe, Boerje
    Mitchell, Malcolm I.
    Linnebjerg, Helle
    Leishman, Derek J.
    Mehrotra, Nitin
    Zhu, Hao
    Koerner, John
    Fiszman, Monica L.
    Balakrishnan, Suchitra
    Xiao, Shen
    Todaro, Thomas G.
    Hensley, Ingrid
    Guth, Brian D.
    Michelson, Eric L.
    Sager, Philip
    AMERICAN HEART JOURNAL, 2015, 170 (01) : 23 - 35